Parkinson's Disease
Parkinson's Disease (PD) is a long-term neurodegenerative disorder primarily affecting the central nervous system, characterized by motor symptoms like tremor, slowness of movement, rigidity, and balance issues, as well as non-motor symptoms including depression, dementia, sleep problems, and neuropsychiatric issues. The disease is caused by the progressive loss of dopamine-producing neurons in the brain, leading to worsening symptoms over time.
Health Outcomes
- Activated Mitophagy Pathway
- Alleviated Constipation Symptoms
- Altered Catecholamine Level
- Altered Monoamine Signaling
- Altered Neurobiological Markers
- Changed Functional Connectivity
- Changed Walking Cadence
- Decreased Blood Toxic Amines Levels
- Decreased Composite Scores
- Delayed Disease Progression
- Delayed Neurodegeneration
- Enhanced Antioxidant Activity
- Enhanced Antioxidant Response
- Enhanced Auto-aggregation Ability
- Enhanced Autophagy
- Enhanced BDNF-TrkB Signaling
- Enhanced Endoplasmic Reticulum Stress Response
- Enhanced Functional Traits
- Enhanced Mitochondrial Biogenesis
- Enhanced Neurogenesis in Adults
- Enhanced Neurological Disorder Management
- Enhanced Neuropharmacological Function
- Enhanced Superoxide Dismutase Activity
- Extended Lifespan in Caenorhabditis elegans
- Extended ON State
- Facilitated Mitophagy
- Impaired Vacuolar Function
- Improved 6-Meter Walk Performance
- Improved 6-minute Walking Distance
- Improved Activities of Daily Living
- Improved Agility Performance
- Improved Agility and Coordination Performance
- Improved Aging-Related Changes
- Improved Anaerobic Power
- Improved Antioxidant Activity
- Improved Antioxidative Capacity
- Improved Antioxidative Enzyme Activities
- Improved Antioxidative Response
- Improved Average Power During Leg Press
- Improved Barthel Index
- Improved Barthel Index Score
- Improved Blood-Brain Barrier Function
- Improved Blood-Brain Barrier Integrity
- Improved Brain Activity
- Improved Brain Function
- Improved Brain Health
- Improved Brain-Derived Neurotrophic Factor Level
- Improved Catecholamine Status
- Improved Central Nervous System Function
- Improved Cognition
- Improved Cognitive Function
- Improved Cognitive Orientation Function
- Improved Cognitive Performance
- Improved Cognitive Score
- Improved Cognitive Screen Score
- Improved Communication
- Improved Communication Skills
- Improved Constipation Management
- Improved Cytoprotection During Oxidative Stress
- Improved Daily Activity Participation
- Improved Decision Accuracy
- Improved Delayed Memory
- Improved Distance Traveled
- Improved Dopamine Transporter Binding
- Improved Duration of OFF Period
- Improved Enjoyment of Life
- Improved Fatigue Symptoms
- Improved Fatigue Threshold
- Improved Fine Motor Skills
- Improved Five Times Sit-to-Stand Time
- Improved Function Score
- Improved Functional Capacity
- Improved Functional Outcome
- Improved Functional Recovery
- Improved Gait Speed
- Improved General Activity
- Improved Global Clinical Impression
- Improved Global Clinical Status
- Improved Global Quality of Life
- Improved Glutathione Level
- Improved Glutathione Redox Ratio
- Improved Gross Motor Function
- Improved Intestinal Transit
- Improved Isokinetic Strength
- Improved Knee Extensor Strength
- Improved Leg Extension Strength
- Improved Leg Strength
- Improved Lower Body Endurance
- Improved Lower Body Power
- Improved Lower Body Strength
- Improved Lower Limb Peak Power
- Improved Lower-Body Muscular Strength
- Improved MMSE Score
- Improved Maximal Power
- Improved Maximal Walking Performance
- Improved Memory Performance
- Improved Mini-Mental State Examination Score
- Improved Mitochondrial Function
- Improved Motivation to Move
- Improved Motor Function
- Improved Motor Speed
- Improved Motor Symptom
- Improved Muscle Function Recovery
- Improved Muscular Endurance
- Improved Neurodegenerative Disease Symptoms
- Improved Neurodegenerative Disorder
- Improved Neurological Health
- Improved Neurological Symptoms
- Improved Neuromuscular Power
- Improved Neuromuscular Strength
- Improved Neuronal Survival
- Improved Neuroplasticity Biomarkers
- Improved Neuroprotection
- Improved Neurotransmitter Metabolism
- Improved Neurotransmitter Profile
- Improved Neurotrophic Signaling
- Improved Non-Motor Symptoms
- Improved OFF State Motor Symptoms
- Improved ON Period Duration
- Improved Oxidative Stress Marker
- Improved Oxidative Stress Tolerance
- Improved Parkinson's Disease Motor Symptoms
- Improved Parkinson's Disease Symptoms
- Improved Passing Performance
- Improved Peak Power
- Improved Physical Domain Score
- Improved Physical Function
- Improved Physical Mobility
- Improved Physical Performance
- Improved Physical Quality of Life
- Improved Physical and Cognitive Performance
- Improved Processing Speed
- Improved Psychomotor Skill
- Improved Quadriceps Function
- Improved Quadriceps Strength
- Improved Quality of Life
- Improved Rate of Force Development
- Improved Reaction Time
- Improved Redox Homeostasis
- Improved Saliva Flow Rate
- Improved Set-Shifting Reaction Time
- Improved Shooting Performance
- Improved Simulated Game Total Completion Time
- Improved Sprint Power Output
- Improved Standing Balance
- Improved Stiffness
- Improved Superoxide Dismutase Activity
- Improved Superoxide Dismutase Level
- Improved Symptom Control
- Improved Synaptic Plasticity
- Improved Total Antioxidative Status
- Improved Transit Time
- Improved Treatment Efficacy
- Improved Unified Parkinson Disease Rating Scale Part III Score
- Improved Unified Parkinson's Disease Rating Scale Score
- Improved Vertical Jump
- Improved Visual-Spatial Function
- Improved Visuo-Cognitive Processing
- Improved Walking Ability
- Improved Walking Distance
- Improved Walking Speed
- Improved Working Memory
- Increased Acetylcholine Levels
- Increased Autophagy
- Increased Carnosine Level
- Increased Catalase Expression
- Increased Constipation Risk
- Increased Cysteine Level
- Increased Expression of Heat Shock Protein 25
- Increased GSH/GSSG Ratio
- Increased Glutathione Disulfide Ratio
- Increased Glutathione Level
- Increased Glutathione Levels
- Increased Glutathione Peroxidase Activity
- Increased Malondialdehyde Levels
- Increased Mobility in Aging Worms
- Increased NRF2 Levels
- Increased Need for Repeated Dosing
- Increased Neurogenesis
- Increased Neuronal Cell Survival
- Increased Nrf2 Level
- Increased Nrf2 Protein Content
- Increased Oxidative Stress
- Increased Oxidative Stress Tolerance
- Increased Prefrontal Cortex Deoxygenated Hemoglobin Level
- Increased Proportion of Responders
- Increased Reactive Oxygen Species Production
- Increased Reactive Oxygen Species Response
- Increased Saliva Production
- Increased Superoxide Dismutase Activity
- Increased Superoxide Dismutase Level
- Increased Thiol Level
- Increased Time in Bed
- Increased Time to Exhaustion
- Increased Total Serum Antioxidant Capacity
- Increased Total Thiol Level
- Increased Walking Speed
- Maintained Acetylcholine Levels
- Maintained Cognitive Function
- Maintained Physical Condition
- Maintained Vigorous Locomotion
- Modified Resting-State Brain Connectivity
- Modulated Microbiota-Gut-Brain Axis
- Nervous System Dysfunction in Host
- Neuroprotection Against Dopamine Neuronal Loss
- Neuroprotection in Neurodegenerative Diseases
- No Change in Plasma GABA Levels
- No Clear Effect on Depression
- No Significant Improvement in Locomotor Activity
- No Significant Improvement in Memory Retention
- Preserved Dopaminergic Neurons
- Preserved Hippocampal Neurogenesis
- Preserved Wheel-Running Activity
- Prevented Neurometabolic Decline
- Prevention of Neurological Disorders
- Reduced Accommodation Variability
- Reduced Aging-related Changes
- Reduced Alpha-Synuclein Accumulation
- Reduced Anhedonia
- Reduced Behavioral Deficits in Parkinson's Disease Model
- Reduced Brain Atrophy
- Reduced Brain Inflammation
- Reduced Brain Oxidative Stress
- Reduced Cadence
- Reduced Catalase Activity
- Reduced Central Nervous System Symptom Severity
- Reduced Choking Index
- Reduced Cognitive Function
- Reduced Confusion and Bewilderment
- Reduced Constipation
- Reduced Constipation Symptoms
- Reduced Cytoskeleton Disruption
- Reduced Defecation Frequency
- Reduced Disability
- Reduced Dopamine Levels
- Reduced Duodenal Pressure
- Reduced Dysphagia
- Reduced Dysphagia Symptom Score
- Reduced Extrapyramidal Symptoms
- Reduced Fall Incidence
- Reduced Fall Risk
- Reduced Fatigue Severity
- Reduced Feeding Difficulties
- Reduced Gastric Emptying
- Reduced Glial Cell Activation
- Reduced Glutamate Level
- Reduced Glutathione Loss
- Reduced Heart Rate Variability
- Reduced Heat Intolerance
- Reduced Heat Stress
- Reduced Hydrogen Sulfide Level
- Reduced Incidence of Adverse Events
- Reduced Incidence of Aspiration Pneumonia
- Reduced Lipofuscin Accumulation
- Reduced Locomotor Impairment
- Reduced Lymphocytic Genome Damage
- Reduced Malonaldehyde Levels
- Reduced Missed Response
- Reduced Muscular Endurance
- Reduced N-acetylaspartate Level
- Reduced NADPH Oxidase Activity
- Reduced Neurodegeneration Symptoms
- Reduced Neurodegenerative Disease-Related Dysfunction
- Reduced Neuroinflammation
- Reduced Neuroinflammatory Markers
- Reduced Neurological Symptoms
- Reduced Neuronal Death
- Reduced Neurotoxicity
- Reduced Nuclear Factor Kappa-B Level
- Reduced Oxidative Stress
- Reduced Oxidative Stress Index
- Reduced Oxidative Stress Marker
- Reduced Oxidative Stress Marker Level
- Reduced Oxidized Glutathione Level
- Reduced Protein Carbonyl Level
- Reduced Protein Carbonyl Levels
- Reduced Protein Oxidation
- Reduced Proteotoxicity
- Reduced Reaction Time
- Reduced Relative Abundance of Coprococcus Genus
- Reduced Response Time
- Reduced Response Time on Flanker Task
- Reduced Serum BDNF Levels
- Reduced Serum Kynurenine Levels
- Reduced Set-Shifting Reversal Error
- Reduced Simple Reaction Time
- Reduced Stiffness
- Reduced Swimming Time
- Reduced Sympathetic Hyperactivity
- Reduced Tremor
- Reduced Urgency
- Reduced Urinary Urgency
- Reduced Walking Time
- Reduced cFos Expression in Brain Areas
- Reduced α-Synuclein Levels
- Regulated Microglial Activation
- Restored Neurodegeneration-Associated Metabolic Alterations
- Restored SOD Activity Levels
- Stabilized Disease Progression
- Stabilized Dopamine Pathway Function
- Stabilized Neurofilament Light Chain Level
- Stable Brain Metabolite Levels
- Stable Long-Term Function
- Stable Salivation Rate
- Supported Physiological Function in Elderly